Status
Conditions
Treatments
About
The purpose of this decentralised study in a real-world setting is to assess the effectiveness of a marketed denture adhesive (Poligrip Power Max Hold + Seal) in preventing food entrapment under dentures (self-assessed). The study will evaluate participants perceived food occlusion of a marketed denture adhesive over three weeks compared to no adhesive use over three weeks in a real-world setting.
Full description
This will be an open-labelled, decentralised, 6-week study to assess the effectiveness of food occlusion of a marketed denture adhesive in healthy partial and/or full denture wearers aged 18 and above in a real-world setting. Study comprises of 3 weeks of no adhesive use (Day 1 to 21) followed by 3 weeks of adhesive use (Day 22 to 42). Participants will complete Daily Food Occlusion Questions for 3 weeks without using adhesive cream and another 3 weeks with using adhesive cream. Sufficient participants will be screened to enroll approximately 375 participants to ensure that around 300 of these participants will successfully complete the entire study. Participants will be recruited through digital platforms through pre-screening questionnaires followed by a screening virtual visit.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
An employee either directly involved in the conduct of the study or a member of their immediate family; or an employee of Lindus Health otherwise supervised by the investigator; or, a Haleon employee directly involved in the conduct of the study or a member of their immediate family.
A participant who has participated in other studies (including non-medicinal studies) involving investigational product(s) within 30 days prior to study entry and/or during study participation.
A participant who has been previously enrolled in this study.
Participants who have a clinical condition as self-reported on the screening questionnaire, which include:
A participant who is diagnosed with xerostomia or is taking any medication that is causing xerostomia.
A participant with known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
A participant who has a recent history (within the last year) of alcohol or other substance abuse.
A participant who has history of swallowing difficulties or choking.
Participants must not receive any denture-related adjustments or treatments that alter fit, comfort or structure of their denture during the study.
Currently taking or have taken a bisphosphonate drug (that is., Fosamax, Actenol, Boniva).
A participant who reports a planned surgery during the study duration.
A participant who, in the opinion of the investigator or delegate, should not participate in the study.
A participant who is unable to read and understand English.
Primary purpose
Allocation
Interventional model
Masking
375 participants in 1 patient group
Loading...
Central trial contact
Haleon Response Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal